12:00 AM
Mar 25, 2002
 |  BC Week In Review  |  Company News  |  Deals

Altachem deal

AAF purchased from an undisclosed party exclusive rights to an immunomodulator for 400,000 AAF shares...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >